Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioCeuticals is a leading Australian provider of practitioner-only nutritional and therapeutic supplements, specializing in evidence-based complementary medicines. Founded in 1993 and acquired by the Blackmores Group in 2012, the company offers a wide range of vitamins, minerals, herbal products, and probiotics designed for clinical use. Its products, such as the Ultra Muscleze magnesium range, are distributed exclusively through healthcare professionals to ensure they are accompanied by expert advice. BioCeuticals emphasizes research and education through its fx Medicine platform and collaboration with the Blackmores Institute. Following the acquisition of Blackmores by Kirin Holdings in 2023, BioCeuticals operates as part of Kirin's Health Science business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioCeuticals.